Cluster Analysis in Patients with GOLD 1 Chronic Obstructive Pulmonary Disease

Background We hypothesized that heterogeneity exists within the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 1 spirometric category and that different subgroups could be identified within this GOLD category. Methods Pre-randomization study participants from two clinical trials were symptomatic/asymptomatic GOLD 1 chronic obstructive pulmonary disease (COPD) patients and healthy controls. A hierarchical cluster analysis used pre-randomization demographics, symptom scores, lung function, peak exercise response and daily physical activity levels to derive population subgroups. Results Considerable heterogeneity existed for clinical variables among patients with GOLD 1 COPD. All parameters, except forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC), had considerable overlap between GOLD 1 COPD and controls. Three-clusters were identified: cluster I (18 [15%] COPD patients; 105 [85%] controls); cluster II (45 [80%] COPD patients; 11 [20%] controls); and cluster III (22 [92%] COPD patients; 2 [8%] controls). Apart from reduced diffusion capacity and lower baseline dyspnea index versus controls, cluster I COPD patients had otherwise preserved lung volumes, exercise capacity and physical activity levels. Cluster II COPD patients had a higher smoking history and greater hyperinflation versus cluster I COPD patients. Cluster III COPD patients had reduced physical activity versus controls and clusters I and II COPD patients, and lower FEV1/FVC versus clusters I and II COPD patients. Conclusions The results emphasize heterogeneity within GOLD 1 COPD, supporting an individualized therapeutic approach to patients. Trial registration www.clinicaltrials.gov. NCT01360788 and NCT01072396.

[1]  R. Casaburi,et al.  The Continuum of Physiological Impairment during Treadmill Walking in Patients with Mild-to-Moderate COPD: Patient Characterization Phase of a Randomized Clinical Trial , 2014, PloS one.

[2]  Thierry Troosters,et al.  An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. , 2013, American journal of respiratory and critical care medicine.

[3]  M. Decramer,et al.  Daily physical activity in subjects with newly diagnosed COPD , 2013, Thorax.

[4]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[5]  F. Maltais,et al.  Walking exercise response to bronchodilation in mild COPD: a randomized trial. , 2012, Respiratory Medicine.

[6]  F. García-Río,et al.  Prognostic value of the objective measurement of daily physical activity in patients with COPD. , 2012, Chest.

[7]  R. J. Shephard,et al.  Physical Activity Is the Strongest Predictor of All-Cause Mortality in Patients With COPD: A Prospective Cohort Study , 2012 .

[8]  J. Guenette,et al.  Sex differences in exertional dyspnea in patients with mild COPD: Physiological mechanisms , 2011, Respiratory Physiology & Neurobiology.

[9]  Olaf Holz,et al.  Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. , 2011, Chest.

[10]  D. Jensen,et al.  Lung Hyperinflation and Its Reversibility in Patients with Airway Obstruction of Varying Severity , 2010, COPD.

[11]  Edwin K Silverman,et al.  Characterisation of COPD heterogeneity in the ECLIPSE cohort , 2010, Respiratory research.

[12]  M. Weatherall,et al.  Use of cluster analysis to define COPD phenotypes , 2010, European Respiratory Journal.

[13]  Edwin K Silverman,et al.  Chronic obstructive pulmonary disease phenotypes: the future of COPD. , 2010, American journal of respiratory and critical care medicine.

[14]  Thierry Troosters,et al.  Physical inactivity in patients with COPD, a controlled multi-center pilot-study. , 2010, Respiratory medicine.

[15]  P. Macklem.  Therapeutic implications of the pathophysiology of COPD , 2010, European Respiratory Journal.

[16]  D. Caillaud,et al.  Clinical COPD phenotypes: a novel approach using principal component and cluster analyses , 2010, European Respiratory Journal.

[17]  M. Polkey,et al.  The prevalence of quadriceps weakness in COPD and the relationship with disease severity , 2009, European Respiratory Journal.

[18]  H. Magnussen,et al.  Physical activity in patients with COPD , 2008, European Respiratory Journal.

[19]  J Stocks,et al.  Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction , 2008, Thorax.

[20]  P. Laveneziana,et al.  Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[21]  E. Petsonk,et al.  Definition of COPD GOLD stage I. , 2007, Thorax.

[22]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[23]  William M Vollmer,et al.  Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? , 2006, Thorax.

[24]  C. Lenfant,et al.  Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease , 2006 .

[25]  J. Hankinson,et al.  Interpretative strategies for lung function tests , 2005, European Respiratory Journal.

[26]  H. Kerstjens.  The GOLD classification has not advanced understanding of COPD. , 2004, American journal of respiratory and critical care medicine.

[27]  J. Gea,et al.  Relevance of assessing quadriceps endurance in patients with COPD , 2004, European Respiratory Journal.

[28]  A. Gulsvik,et al.  Remission of respiratory symptoms by smoking and occupational exposure in a cohort study , 2004, European Respiratory Journal.

[29]  Janos Porszasz,et al.  A treadmill ramp protocol using simultaneous changes in speed and grade. , 2003, Medicine and science in sports and exercise.

[30]  W. Bailey,et al.  Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.

[31]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[32]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[33]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[34]  M. S. Singh,et al.  Development of a shuttle walking test of disability in patients with chronic airways obstruction. , 1992, Thorax.

[35]  G J McLachlan,et al.  Cluster analysis and related techniques in medical research , 1992, Statistical methods in medical research.

[36]  G. W. Milligan,et al.  An examination of procedures for determining the number of clusters in a data set , 1985 .

[37]  C. Wells,et al.  The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. , 1984, Chest.

[38]  Sue Dy,et al.  Normal values in adults during exercise testing. , 1984 .

[39]  J. E. Hansen,et al.  Normal values in adults during exercise testing. , 1984, Clinics in chest medicine.

[40]  G. Borg.  Psychophysical bases of perceived exertion. , 1982, Medicine and science in sports and exercise.

[41]  J. H. Ward.  Hierarchical Grouping to Optimize an Objective Function , 1963 .

[42]  P. Hugh-Jones,et al.  Terminology for Measurements of Ventilatory Capacity , 1957, Thorax.